Angle Share Discussion Threads

[gooosed] 14/7/2024 10:47

raddersSandy - good morning & thankyou for the detail, much appreciated.

Better by far to iron out any wrinkles at this stage than to suffer post development setbacks. Two FDA cleared pieces of kit providers combining to develop novel cutting edge MedTech sets a high bar.

[radderssandy] 14/7/2024 10:10

Morning Gooosed,

Just to elaborate a little further on the Bioview timings. There was a ‘clue’ in IG’s financial statement in the Annual General Report - “The assay development phase made good progress in 2023 and is estimated to complete in H1-2025 and will generate revenue for ANGLE of £1.2 million.” (Page 42). I queried this date in an email to the company and they confirmed the revised timeline.

I also spoke to AN on the day of the AGM. Bioview have made some modifications to the microscope. Overall the program is going well and AN is pleased with the “output” they have got, but they have had “one or two stop starts whilst they they wait for Bioview to sort various things” and this has caused a delay.

[gooosed] 14/7/2024 09:26

miavoce - thankyou for your response to the question re Bioview.

[kryptonsnake] 14/7/2024 08:25

Some people fail to realise we comfortably reached 25p on the back of 2 Astra deals

The 15p placing gave Angle over £9 million to work with

Add in all the discussions with large pharma and we're in a much stronger position now

That's why the share price won't hang around 15p much longer. It will move very quickly at the sniff of any new deal



sent from my iPhone

[adw198] 14/7/2024 01:12

@outsized

That’s a good and fair question. And I note 3 people have given you the thumbs up. But the company have apparently just said they hope to do 1-2 deals this half, not the 2-3 you’ve speculated. The company haven’t mentioned phase 2 trials. The January deal hasn’t led to anything else yet - admittedly it might. It’s fair to say there could be a big phase 2 deal around the corner, but let’s be honest nobody here can explain how that might work. Even if a further / follow up contract is signed when will the revenue land and how much will it cost us to do the work, ie what’s the margin?

At some point the market will need to signs of a successful business and not the jam tomorrow potential that’s being speculated about.

[outsizeclothes.com] 13/7/2024 20:16

What IF the Company announced missed 6m revenue, but before that announced 2 or 3 more AZ type initial deals?
Would the strength of the deals, on top of perhaps AZ going to phase 2, not more than compensate for a, let's say, 2.5m miss?
I believe it would.

[bones698] 13/7/2024 15:18

Ah OK I was thinking August because they are not embargoed by the US securities then. Suits me having a bit more time and to see if we get any news between now and then. I'm more focused on the AZ trial that's due up in October as an indicator of how things will progress to me if that culminated in a larger study then that will be good news

[radderssandy] 13/7/2024 14:53

Hi Bones,

From what I heard from the AGM feedback, the next business update will be in September. Possibly when the interim results are released?

[miavoce] 13/7/2024 14:16

Me too Bones698, me too.

[bones698] 13/7/2024 13:22

Let's hope they have then. I look forward to the trading update in August to see.

[miavoce] 13/7/2024 13:17

Hi Bones698

I am as much in the dark as the rest of us regarding where the H2 revenue lift will come from. However I am reassured by the fact that, even as late as mid July, AN and IG are both expressing confidence in meeting the analysts forecast. The Angle board must have learned the lesson from early 2023 of setting revenue expectations too high and I would be very surprised if they were to make that mistake again. They clearly must know something we don't.

[kryptonsnake] 13/7/2024 13:15

bones698

The fact is you don't know what's going to happen

Angle could deliver the Astra work earlier than expected and would give a large boost to revenues

You've repeated several times that you're out and not coming back until September time

Leave it at that or you're going to start sounding like Adw



sent from my iPhone

[bones698] 13/7/2024 13:04

Hi Mia Thanks for the reply, I would argue AN is rarely conservative and gets carried away and over states. IG is the opposite from my experience
Thier internal forecasting is based on what they believe but as last year showed and so far this year with 1m of the 6. 6 accounted for it isn't looking good.

You didn't explain how 1 or 2 more deals will generate such a high amount of revenue.

The only rabbit out of the hat for me that would generate anywhere close is the initial AZ deal moving onto the next phase quickly when concluded in late October but even then I believe the next phase would be 1-3m in size and that's if it happens and if concluded in time

Is there a chance of the proverbial rabbit out the hat, yes of course but this is a game of odds as we are all guessing and this year's progress seems to have slowed and been delayed on several fronts. I doubt this improves those odds.

Dermot increasing is good news

To me the recent raise at a decent price looks like a get it while they can incase they miss revenue target and the price falls scenario

[bagpuss67] 13/7/2024 11:39

Re Her2 it seems they have an assay which they are using for Esaai but they want to do more tests before they launch a kit. Let's hope that Roche (or Abbott) want to join the party at some point.

[miavoce] 13/7/2024 11:14

1. Bioview - AN has advised (see Telegram group) that during the development work BioView decided to make some changes to their system so this created a delay. The work is expect now to complete in H1 2025. This is out of Angle's control and was not predictable.

2. Do Angle forecast ? Well clearly they do have forecasts internally otherwise how can they repeatedly say they expect to be cashflow break even by end 2025 ? Whether they make these forecasts available to analysts is a different matter entirely.

3. Feedback from the AGM is that AN & IG (usually very conservative) both confirmed that they are confident the revenue forecast made by analysts (£6.4m) will be met.

[sinzu] 13/7/2024 11:02

Guys, just FILTER the idiots - I have no idea what they are saying and I don't want to know.

[gooosed] 13/7/2024 10:55

bones698 - I've clearly missed it, so can you confirm your source for the Bioview assertion ?

[bagpuss67] 13/7/2024 10:31

Having said that great to see that that are still talking to some big names. Very encouraging that they seem to be building a relationship with Illumina and that Roche still seem to a firm that may be able to sign up.

[bones698] 13/7/2024 10:30

From the feedback from the agm several time lines have slipped namely bioview and thermo Fisher. AN expects one or two more deals to be signed this year. This is not made up this is what's been said. How do you see one or 2 more deals generating 5m in revenue for H2? Given these deals are likely to be similar in size to what we have seen 200-600k. The old excuse timeliness are out of their control keeps popping up.

Simply put they look far more likely to miss revenue again and the last time this happened the share price crashed from 40p to 10p. Longer term the prospects still look good but the constant delays are pushing timeliness further away.
They raised money when they said they didn't need to why?
The trading update will be interesting and I'll wait until after that to decide whether to buy in or not now as the risk of the revenue miss looks a lot higher than it was. What the rest decide to do is upto them

[bagpuss67] 13/7/2024 10:28

I also find it very odd they say they don't forecast. If that's true then its even less of a surprise that they had to do a raise to satisfy the auditors. Indeed, every year they will need enough cash to cover contracted revenue less costs to avoid a qualification if they can't/ won't forecast.

Also brings into focus that they can't really be confident in the revenue target for the year if they can't call that a revenue forecast and turn it into an overall forecast.

[kryptonsnake] 13/7/2024 09:04

Adw is best enjoyed on filter

He's done nothing but talk the company down since he sold at 16p and watched it move to 25p

I even told him he should get back in but of course he was too stupid to see it was heading to 25p

Some say he likes to argue with his own reflection



sent from my iPhone

[kryptonsnake] 13/7/2024 08:58

It's so nice of all the non holders to show up and warn us of how dire the situation is for Angle

Did they miss the boat at 14p and are now worried it's going to move higher next week

All the shorts have closed so you now have a small window of opportunity to start buying before this moves up rapidly



sent from my iPhone

[htrocka2] 13/7/2024 08:58

Adw...Dermot Keane increased his holding to 26m shares...All you've done is to help him buy cheap shares. He can see plenty of 'up-side' here. I'm still trying to work out exactly who you're working for and what your agenda is?.

[whyisthistaking50long] 13/7/2024 08:51

Isn't running a retail business without revenue forecasts abit .....weird? Don't all come for me please - I'm just bemused by the absence of projections mentioned earlier.